Anp Board to bring home the bacon..ROI, page-67

Also Gassy, regarding the 'monkey plasma'.  You might be happy with the explanation but look at it this way.

Since they first announced '...the Company’s plan to submit a U.S. Investigational New Drug (IND) application for initiation of longer term Phase IIb human trials of ATL1102 for the treatment of Multiple Sclerosis (MS).' - back in OCTOBER 2014

Using a rough approximate cash burn of $1m per quarter, we could assume that since Oct 14 the coy has burned around $5m.  Give or take.

What advancements has ANP made to any of it's prospects for $5m?

We know that
-they have maintained an office in (according to google), Melbourne's most expensive suburb.
-taken home huge salaries
-traveled to the US multiple times.

Do you think that $5m could of been put to better use, had they been able to resolve the 'monkey plasma problem' in a more timely fashion?

A rough estimate of $5m cash burned, over 1 year and still no IND application.

"By the book"